If you thought that Chantix was the only anti-smoking drug that was linked to Stevens-Johnson syndrome (SJS), think again. Another smoking cessation drug, Zyban, has been linked to the debilitating condition. This can leave many people to wonder which of the drugs to use, if either.
First of all, let me tell you that both drugs have the potential to cause adverse side effects like aggressive behaviour, mood swings, depression, SJS and diabetes. Both drugs were issued black box warnings by the FDA for their psychological side effects and risk of SJS in 2009. With serious psychological side effects and SJS as warnings, many smokers that took either drug now are filing lawsuits against the makers of them.
People try to quit smoking to make their health better, not worse. Side effects like these can cause long-term suffering that can make smoking side effects feel like the least of their problems. The problem is that drug makers like Pfizer (makers of Chantix) and GlaxoSmithKline (makers of Zyban) are being accused of not conducting enough research before putting the drugs on the market. Zyban is most frequently linked to seizures.
The fact that both drugs are now linked to SJS may play a large factor in patients deciding not to use the drugs. SJS is a rare skin disease that causes the body to burn from the inside out. It is painful and potentially fatal, and can happen to just about anyone. Right now, no one knows just who can be affected by SJS or what triggers the severe allergic reaction. That is what makes the condition so scary. You never know if it will hit or why.
If you have taken Chantix or Zyban and developed SJS as a result of it, contact SJS attorney Greg Jones today for a free consultation. I am experienced at fighting SJS lawsuits and may be able to help you recover money for your injuries.